Hisamitsu Pharmaceutical Co., Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HTSUY research report →
About the company
Hisamitsu Pharmaceutical Co. , Inc. is a company dedicated to the entire lifecycle of healthcare products, from initial research and development to manufacturing and global distribution of pharmaceuticals and related health solutions.
- CEO
- Kazuhide Nakatomi
- IPO
- 2017
- Employees
- 2,769
- HQ
- Tosu, JP
Price Chart
- Market Cap
- $839.03M
- P/E
- 22.44
- P/S
- 2.61
- P/B
- 1.46
- EV/EBITDA
- 11.06
- Div Yield
- 1.99%
- Gross Margin
- 58.96%
- Op Margin
- 10.99%
- Net Margin
- 11.75%
- ROE
- 6.99%
- ROIC
- 4.66%
- Revenue
- $1.09B · 6.32%
- Net Income
- $127.84M · -10.40%
- EPS
- $0.45 · -6.25%
- Op Income
- $119.55M
- FCF YoY
- 87.81%
- 52W High
- $9.42
- 52W Low
- $2.94
- 50D MA
- $6.65
- 200D MA
- $6.74
- Beta
- 0.04
- Avg Volume
- 4
Get TickerSpark's AI analysis on HTSUY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our HTSUY coverage
Recent articles, reports, and earnings notes.
No research on HTSUY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HTSUY report →Similar companies
Peers in the same neighborhood.